Literature DB >> 10068387

Association between the Epworth sleepiness scale and the multiple sleep latency test in a clinical population.

S R Benbadis1, E Mascha, M C Perry, B R Wolgamuth, L A Smolley, D S Dinner.   

Abstract

BACKGROUND: Excessive daytime sleepiness can be evaluated with both subjective and objective tests.
OBJECTIVE: To examine the association between Epworth Sleepiness Scale scores and sleep latency on the multiple sleep latency test.
DESIGN: Case series.
SETTING: Referral sleep disorders center. PATIENTS: 102 consecutive patients evaluated for excessive daytime sleepiness. MEASUREMENTS: Epworth Sleepiness Scale scores and mean sleep latency on the multiple sleep latency test.
RESULTS: No significant association was seen between Epworth scores and mean sleep latency (Pearson correlation, -0.17 [95% CI, -0.35 to 0.03]; P = 0.09) (analysis of variance, P = 0.13). The mean Epworth score did not differ in three groups of patients who were defined by mean sleep latency as having normal sleep latency (>10 minutes), moderate sleep latency (5 to 10 minutes), or severe sleep latency (<5 minutes) (analysis of variance, P = 0.13).
CONCLUSIONS: No statistically or clinically significant association was seen between Epworth scores and mean sleep latency. The subjective Epworth Sleepiness Scale and the objective multiple sleep latency test may evaluate different, complementary aspects of sleepiness.

Entities:  

Mesh:

Year:  1999        PMID: 10068387     DOI: 10.7326/0003-4819-130-4-199902160-00014

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  40 in total

1.  Reliability of a single objective measure in assessing sleepiness.

Authors:  Bernie Y Sunwoo; Nicholas Jackson; Greg Maislin; Indira Gurubhagavatula; Charles F George; Allan I Pack
Journal:  Sleep       Date:  2012-01-01       Impact factor: 5.849

2.  Classification algorithms for predicting sleepiness and sleep apnea severity.

Authors:  Nathaniel A Eiseman; M Brandon Westover; Joseph E Mietus; Robert J Thomas; Matt T Bianchi
Journal:  J Sleep Res       Date:  2011-07-14       Impact factor: 3.981

3.  Abuse of the Epworth Sleepiness Scale.

Authors:  Stuart F Quan
Journal:  J Clin Sleep Med       Date:  2013-10-15       Impact factor: 4.062

4.  Inflammatory proteins in patients with obstructive sleep apnea with and without daytime sleepiness.

Authors:  Mónica de la Peña Bravo; Laura D Serpero; Antonia Barceló; Ferran Barbé; Alvar Agustí; David Gozal
Journal:  Sleep Breath       Date:  2007-09       Impact factor: 2.816

5.  For individuals with obstructive sleep apnea, institution of CPAP therapy is associated with an amelioration of symptoms of depression which is sustained long term.

Authors:  Daniel J Schwartz; Gillian Karatinos
Journal:  J Clin Sleep Med       Date:  2007-10-15       Impact factor: 4.062

6.  Reliability and validity of a Norwegian version of the Epworth sleepiness scale.

Authors:  Kornelia K Beiske; Frank N Kjelsberg; Espen A Ruud; Knut Stavem
Journal:  Sleep Breath       Date:  2008-06-17       Impact factor: 2.816

7.  Epworth sleepiness scale scores and adverse pregnancy outcomes.

Authors:  Ghada Bourjeily; Rana El Sabbagh; Peter Sawan; Christina Raker; Carren Wang; Beth Hott; Mariam Louis
Journal:  Sleep Breath       Date:  2013-02-19       Impact factor: 2.816

8.  Impact of Sleep-Disordered Breathing Treatment on Patient Reported Outcomes in a Clinic-Based Cohort of Hypertensive Patients.

Authors:  Harneet K Walia; Sandra D Griffith; Nicolas R Thompson; Douglas E Moul; Nancy Foldvary-Schaefer; Reena Mehra
Journal:  J Clin Sleep Med       Date:  2016-10-15       Impact factor: 4.062

9.  Evaluating sleepiness-related daytime function by querying wakefulness inability and fatigue: Sleepiness-Wakefulness Inability and Fatigue Test (SWIFT).

Authors:  R Bart Sangal
Journal:  J Clin Sleep Med       Date:  2012-12-15       Impact factor: 4.062

10.  Obstructive sleep apnea alters sleep stage transition dynamics.

Authors:  Matt T Bianchi; Sydney S Cash; Joseph Mietus; Chung-Kang Peng; Robert Thomas
Journal:  PLoS One       Date:  2010-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.